By Maggie Fick LONDON, July 24 (Reuters) – AstraZeneca's long-time CEO Pascal Soriot has rarely put a foot wrong. The company's shares have more that quadrupled in price during his 14-year tenure,
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
US consumer sentiment near record low ahead of midterm elections
Oct 23 (Reuters) - US consumer sentiment edged down to near a record low in…
Exclusive-Fast-fashion group Shein agrees to pay $100 million to settle US FTC probe
By Helen Reid and Jody Godoy LONDON, Oct 23 (Reuters) - Chinese fast-fashion giant Shein…
Exclusive-Fast-fashion group Shein agrees to pay $100 million to settle US FTC probe
By Helen Reid and Jody Godoy LONDON, Oct 23 (Reuters) - Chinese fast-fashion giant Shein…
